EPIX stock why os suspended

``` The deep research logic is organized as follows: Okay, let's tackle this question about why EPIX stock is suspended. First, I need to check the references provided. The user is asking specifically about the suspension of EPIX stock, so I should look through the references for any mentions of stock suspension. Looking at the references, Number 1 mentions "EPIX Suspension Reason" with 0 results found. That's a red flag because it suggests there's no direct data on why EPIX was suspended. Then, I see other references about EPIX stock movements, like the 174.17% surge in 2025-08-25 , but those are about dividends and stock price changes, not suspension. Wait, there's a reference from 2007 (Number 18) where EPIX Pharmaceuticals Inc. received a notice from Nasdaq due to a delayed filing of their 10-K. They were trading at $6.57 then. But that's a different company, right? The current EPIX is ESSA Pharma, which is a different entity. So that might be a mix-up in ticker symbols. The user is asking about EPIX, which is now ESSA Pharma, not the old EPIX Pharmaceuticals. Another reference from 2009 (Number 19) mentions EPIX Pharmaceuticals being delisted from NASDAQ. Again, that's the old company. The current EPIX (ESSA Pharma) is still listed on NASDAQ as of the latest data in 2025. So the suspension isn't due to delisting from NASDAQ. Looking at the 2025 data, there's a mention of a dividend payment causing the stock to surge , but also a drop in price. However, the user is asking about suspension, not price movement. The references don't mention any SEC trading suspension for EPIX. The closest is a general page about SEC trading suspensions (Number 15), but no specific mention of EPIX. Also, the user's query is about the current time, 2025-08-25. The latest earnings report (Number 11, 16, 20, 21, 22) shows ESSA Pharma is winding down operations and distributing capital. They announced a $80M distribution , which caused due bill trading but not suspension. The stock price dropped significantly , but that's due to market reactions, not suspension. Wait, the user might be confusing suspension with delisting. The old EPIX was delisted, but the current EPIX (ESSA) is still active. The references don't show any suspension for EPIX in 2025. The only mention of suspension is the old company in 2009. So the answer should clarify that there's no current suspension for EPIX (ESSA Pharma) and explain the confusion with the old ticker. Also, the user's profile mentions interest in flying cars and technical analysis. Maybe they're mixing up EPIX with another stock, but the data doesn't support that. So the conclusion is that EPIX isn't suspended; the old company was, but the current one isn't. The user might be referring to the old ticker or there's a misunderstanding. ``` **Conclusion** 🚨 **ESSA Pharma (EPIX) stock is NOT currently suspended**. The confusion likely arises from historical data related to a different company (EPIX Pharmaceuticals, Inc.) that was delisted from NASDAQ in 2009 . The current EPIX ticker belongs to ESSA Pharma Inc., which remains actively traded on NASDAQ as of August 25, 2025 . --- ### **Analysis** #### 1. **Current Status of EPIX (ESSA Pharma)** - **Trading Activity**: EPIX shares are actively traded on NASDAQ. Recent price movements reflect market reactions to a $1.69/share dividend payout and strategic restructuring . - **Financial Health**: The company announced a $80M capital distribution to shareholders as part of its winding-down process . This triggered due bill trading on NASDAQ but did not result in a suspension . #### 2. **Historical Context** - **EPIX Pharmaceuticals, Inc. (2007–2009)**: A separate entity with the same ticker symbol was delisted from NASDAQ in 2009 due to non-compliance with listing requirements . This historical suspension does not apply to the current EPIX (ESSA Pharma). #### 3. **Recent Market Reactions** - **Price Volatility**: EPIX shares surged 174.17% pre-market on August 25, 2025, due to the dividend announcement , but later dropped 59% intraday . This reflects investor uncertainty about the company’s future after its strategic transition . - **Strategic Shift**: ESSA Pharma is transitioning to a non-operational status, with plans to distribute remaining assets to shareholders . --- ### **Key Takeaways** - **No Current Suspension**: EPIX (ESSA Pharma) is not suspended; it remains listed on NASDAQ. - **Historical Confusion**: The ticker symbol EPIX has been reused, leading to potential confusion with the delisted EPIX Pharmaceuticals. - **Investor Alert**: The stock’s volatility and strategic wind-down make it a high-risk play for short-term traders . |code|Ticker|Name|market_code| |---|---|---|---| |EPIX|EPIX.O|ESSA Pharma|186|